Youcare Pharmaceutical Group Co. Ltd. A Tangible Net Worth Ratio
Youcare Pharmaceutical Group Co. Ltd. A tangible net worth ratio. Youcare Pharmaceutical Group Co. Ltd. A (688658) has a Tangible Net Worth Ratio of 88.2% as of June 2026. This metric is calculated by deducting intangible assets (CN¥376.02 Million) from net assets (CN¥3.19 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how leveraged is Youcare Pharmaceutical Group Co. Ltd. A's balance sheet to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)
Tangible net worth ratio of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025. This chart shows how Youcare Pharmaceutical Group Co. Ltd. A's Tangible Net Worth Ratio has changed across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 88.2%, reflecting net assets of CN¥3.19 Billion with intangible assets of CN¥376.02 Million CNY. See Youcare Pharmaceutical Group Co. Ltd. A working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Youcare Pharmaceutical Group Co. Ltd. A Tangible Net Worth Ratio by Year (2017–2025)
Youcare Pharmaceutical Group Co. Ltd. A tangible net worth ratio by year from 2017 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Youcare Pharmaceutical Group Co. Ltd. A.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.1% | CN¥3.43 Billion | CN¥443.26 Million | CN¥5.21 Billion | ▼ -0.1 pp |
| 2024 | 87.1% | CN¥3.58 Billion | CN¥460.71 Million | CN¥5.74 Billion | ▼ -0.8 pp |
| 2023 | 87.9% | CN¥3.60 Billion | CN¥434.86 Million | CN¥5.91 Billion | ▼ -2.9 pp |
| 2022 | 90.8% | CN¥4.00 Billion | CN¥368.76 Million | CN¥6.01 Billion | ▼ -2.2 pp |
| 2021 | 92.9% | CN¥3.93 Billion | CN¥277.31 Million | CN¥5.73 Billion | ▼ -1.0 pp |
| 2020 | 93.9% | CN¥3.59 Billion | CN¥217.01 Million | CN¥5.46 Billion | ▲ +11.3 pp |
| 2019 | 82.7% | CN¥1.12 Billion | CN¥194.77 Million | CN¥3.47 Billion | ▲ +4.4 pp |
| 2018 | 78.2% | CN¥842.76 Million | CN¥183.41 Million | CN¥3.42 Billion | ▲ +2.8 pp |
| 2017 | 75.4% | CN¥711.86 Million | CN¥175.12 Million | CN¥3.50 Billion | — |